Trial Profile
Phase II study of ALT-07 in patients with bronchiectasis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2015
Price :
$35
*
At a glance
- Drugs Doxofylline (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- Sponsors Alitair Pharmaceuticals Inc
- 12 Jun 2015 New trial record